News in brief - June 2013

Other new launches, licence changes and prescribing updates relevant to general practice.

Orlistat is used together with dieting in obese patients with BMI ≥30kg/m2, or BMI ≥28kg/m2 with associated risk factors.
Orlistat is used together with dieting in obese patients with BMI ≥30kg/m2, or BMI ≥28kg/m2 with associated risk factors.
  • The anti-obesity agent orlistat (Xenical) is now available as generic capsules.
  • A new presentation of the hepatitis A vaccine Vaqta has been launched for adults.
  • Manufacturers of the FreeStyle InsulinX and OneTouch Verio (‘Pro’ and ‘IQ’) blood glucose meters have warned that the meters can give incorrect readings at very high glucose levels (≥56.8mmol/l) and may need to be returned for replacement.
  • Clomethiazole oral solution (formerly Heminevrin Syrup) has been relaunched; it is licensed for use as a anxiolytic and hypnotic,
  • NICE has updated its guidance on Xolair (omalizumab) in severe persistent allergic asthma, including approval from 6 years of age. 
  • Owing to manufacturing difficulties, the growth deficiency treatment Increlex (mecasermin) will be out of stock from August 2013; prescribers are advised to restrict use to existing patients. 
  • The meningitis ACW134Y vaccine Menveo, in a new presentation containing the solvent in a vial rather than a pre-filled syringe, is now licensed for use ifrom 2 years of age.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases